In recent years, there has been remarkable progress in the field of medical robotics, with the development of millirobots showing great potential in revolutionizing vascular surgery. These tiny screw-shaped devices, fabricated through 3D printing, house a small permanent magnet within. With the ability to navigate through the human circulatory system, the millirobots have the potential to access hard-to-reach arteries and deliver drugs to specific places in the body. In an innovative partnership involving Radboudumc and Triticum Medical (Israel), researchers are poised to enhance the millirobots, enabling them to remotely eliminate blood clots.
Description of the millirobot design
The unique design of the millirobots plays a crucial role in their capabilities. These miniaturized devices measure just one millimeter in length and one millimeter in diameter and feature a screw-shaped structure. Within this structure lies a small permanent magnet, strategically positioned to allow rotation of the screw in both directions. This design enables the millirobots to navigate through the intricate network of blood vessels in the human body.
Successful navigation through the aorta
Using advanced technology, researchers have successfully guided millirobots through the aorta, the main artery of the human body. By employing an X-ray machine, the team was able to pinpoint the millirobot’s location while directing its path through the aorta. This breakthrough achievement demonstrates the precision and control that can be achieved using millirobotic technology.
Anticipation of improved performance
Despite their early success, researchers are eager to apply a stronger magnetic field to the millirobots to allow them to navigate through even higher blood flows. This enhancement is expected to further expand the possibilities of millirobotic technology, establishing its potential as a game-changer in vascular surgery.
Potential benefits in vascular surgery
The use of millirobots in vascular surgeries offers several advantages over current conventional methods. Vascular surgeon Michiel Warle at Radboudumc explains, “Currently, we use blood thinners and flexible tools, but a millirobot can travel to hard-to-reach arteries while requiring only minimal incisions for insertion.” This remarkable capability opens doors to less invasive procedures, reducing patient discomfort and recovery time.
Moreover, millirobots can excel in the precise delivery of drugs to targeted areas of the body. By harnessing their navigational abilities, these robotic devices can reach specific locations where the drug is needed most, maximizing its therapeutic effects. This targeted drug delivery approach holds promise for improving patient outcomes and minimizing potential side effects.
Collaborative research initiative
The exploration and advancement of millirobots in vascular surgery are the result of a collaborative research initiative involving Radboudumc, Triticum Medical, and the University of Twente. To support their efforts, the project has received financial backing from the TURBO (Twente University Radboudumc Opportunities) program. Additionally, Health Holland has recognized the potential of this partnership and recently awarded them a TKI-LSH (Topconsortia for Knowledge & Innovation – Life Sciences & Health) award for their public-private cooperation.
The emergence of millirobots in vascular surgery marks an exciting development in the field of medical robotics. With their ability to navigate through the human circulatory system and remotely eliminate blood clots, these miniaturized devices offer not only great precision and control but also the potential for less invasive procedures. Furthermore, their capacity to deliver drugs to specific places in the body provides new opportunities for personalized medicine. As researchers continue to refine and enhance this technology through collaborative efforts, the impact of millirobots in vascular surgery is poised to revolutionize patient care, leading to improved outcomes and a brighter future for medical robotics.